NCT05926882View on ClinicalTrials.gov

Efficacy of Oral Apremilast in the Treatment of Alopecia Areata at the Tertiary Care Hospital, Karachi.

PHASE4CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

June 20, 2023

Study Completion Date

June 20, 2023

Conditions

Alopecia Areata

Interventions

DRUG

Apremilast 30mg

Patients will be given Oral Apremilast 30 mg twice daily after 05 days titration dose.

Trial Locations (1)

Unknown

JPMC, Karachi

All Listed Sponsors

lead

Jinnah Postgraduate Medical Centre

OTHER_GOV